The Department of Health Care Services posted the following alerts and weekly notices on the Medi-Cal Rx Web Portal. Please note the reinstatement resources and information below.
- Drug Use Review (DUR): Additive Toxicity (AT) – System Issue Resolved (February 6)
- Reinstatement Spotlight (February 3)
- Correction to Alert Link for 30-day Countdown – Reinstatement of Prior Authorization Requirements for 46 Drug Classes Including Medical Supplies (February 3)
- Medi-Cal Rx Weekly Wrap-up for January 27-February 2 (February 3)
- Updated: Appendix H – List of Physician Administered Drugs (PADs) with Reject Code 816 (February 1)
- Updates to Over-the-Counter (OTC) COVID-19 Antigen Test Kits, Effective March 1, 2023 (February 1)
- Medi-Cal Rx Monthly Bulletin for February (February 1)
- Changes to Contract Drugs List (CDL) (February 1)
- Updates to Medi-Cal Rx Provider Manual (February 1)
- Medi-Cal Rx Weekly Wrap-up for January 20-26 (January 27)
- Reinstatement Spotlight (January 27)
Also in California, Medi-Cal posted the following: Medi-Cal Update – Pharmacy – January 2023 – Bulletin 1032 (Correction) (January 31)
Finally in California, the Board of Pharmacy posted agenda and meeting materials for the February 15 meeting of the Enforcement and Compounding Committee.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.